Comparing Accelerated vs. Standard Corneal Crosslinking for Keratoconus
This study is comparing two ways to perform corneal crosslinking for people with keratoconus or corneal ectasia (a condition where the cornea thins and bulges). Researchers are testing if using riboflavin 0.1% eye drops with 9 mW/cm2 UVA light for 10 minutes (accelerated) works as well as using riboflavin 0.1% eye drops with 3 mW/cm2 UVA light for 30 minutes (standard). The study aims to see which method is better at stopping the cornea from getting more curved. You might be able to join if you are at least 10 years old and have documented keratoconus or ectasia after refractive surgery. The study is looking for 510 participants, but its current recruitment status is unclear.
- Study design
- This interventional study plans to enroll 510 participants to compare two different corneal crosslinking methods.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The main measurement of success is taken at 6 months after treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Comparison of Standard vs. Accelerated Corneal Crosslinking
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Francis W Price, Jr., MD · PRINCIPAL_INVESTIGATOR · Price Vision Group
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in maximum keratometry6 months
assessed by corneal tomography